NIH RECOMBINANT DNA ADVISORY COMMITTEE WILL REVIEW SIX PROTOCOLS

NIH RECOMBINANT DNA ADVISORY COMMITTEE WILL REVIEW SIX PROTOCOLS at its Dec. 1-2 meeting. Additionally, the RAC will hear a report by RAC Chairman LeRoy Walters on "minor modifications" to protocols already approved by NIH; a report from the working group on data management pertaining to actions to be taken when principal investigators of NIH-approved gene therapy protocols fail to provide reports to the Office of Recombinant DNA Activities; and a review of Appendix B, the updated list of the Classification of Microorganisms on Basis of Hazard, which by then will have been reviewed by experts from the Centers for Disease Control & Prevention and the American Society for Microbiology. At its Sept. 12-13 meeting, the RAC decided to await letters of concurrence from CDC and ASM before adopting Appendix B.